Royalty Pharma (RPRX) Treasury Shares (2019 - 2026)

Royalty Pharma (RPRX) has 2 years of Treasury Shares data on file, last reported at $18.4 million in Q1 2026.

• For the quarter ending Q1 2026, Treasury Shares rose 2.07% year-over-year to $2.7 million; the trailing twelve-month figure through Mar 2026 stood at $2.7 million (up 2.07% YoY), and the FY2025 full-year result was $2.6 million, down 1.88% from the prior year.
• Treasury Shares rose to $2.7 million in Q1 2026, from $2.6 million in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $2.8 million in Q1 2023 to a low of $2.6 million in Q3 2025.
• A 5-year average of $2.7 million and a median of $2.7 million in 2024 frame the typical range for Treasury Shares.
• Across the five-year window, Treasury Shares gained 15.98% in 2022 and decreased 6.31% in 2023, its largest moves.
• Tracing RPRX's Treasury Shares over 5 years: stood at $2.8 million in 2022, then retreated by 6.31% to $2.6 million in 2023, then grew by 1.26% to $2.7 million in 2024, then fell by 1.88% to $2.6 million in 2025, then gained by 3.71% to $2.7 million in 2026.
• Business Quant data shows RPRX's Treasury Shares at $2.7 million in Q1 2026, $2.6 million in Q4 2025, and $2.6 million in Q3 2025.